日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Baloxavir susceptibility of seasonal influenza viruses during the first seven seasons of clinical use in Japan, 2017/18 to 2023/24

巴洛沙韦在日本临床应用的前七个流感季(2017/18 至 2023/24 年)对季节性流感病毒的敏感性

Takashita, Emi; Fujisaki, Seiichiro; Morita, Hiroko; Nagata, Shiho; Miura, Hideka; Kishida, Noriko; Nakamura, Kazuya; Shirakura, Masayuki; Sato, Aya; Akimoto, Miki; Sugawara, Hiromi; Mitamura, Keiko; Abe, Takashi; Ichikawa, Masataka; Yamazaki, Masahiko; Watanabe, Shinji; Odagiri, Takato; Hasegawa, Hideki

Akhirin Functions as an Innate Immune Barrier to Preserve Neurogenic Niche Homeostasis During Mouse Brain Development.

Akhirin 在小鼠大脑发育过程中发挥着先天免疫屏障的作用,以维持神经发生微环境的稳态。

Kudo Mikiko, Ohkubo Tenta, Sugawara Taichi, Irie Takashi, Hatakeyama Jun, Tamura Shigehiko, Shimamura Kenji, Wakayama Tomohiko, Matsuo Naoki, Nakashima Kinichi, Masuda Takahiro, Ohta Kunimasa

Functional Phytochemicals Cooperatively Suppress Inflammation in RAW264.7 Cells

功能性植物化学物质协同抑制RAW264.7细胞的炎症反应

Terashita, Kaori; Kohakura, Masato; Sugawara, Katsura; Miyagawa, Shinichi; Arimura, Gen-Ichiro

NaClO-oxidized cellulose nanofiber/chitosan composite films with improved water resistance and high mechanical strength

经NaClO氧化的纤维素纳米纤维/壳聚糖复合薄膜具有优异的耐水性和高机械强度

Horathal Pedige, Madhurangika Panchabashini; Onishi, Rika; Hatanaka, Yoshiro; Sugawara, Akihide; Uyama, Hiroshi

Renin-angiotensin system inhibitor use and cardio-renal outcomes in non-proteinuric chronic kidney disease: a post-hoc analysis of the Frontier of Renal Outcome Modification-Japan study

肾素-血管紧张素系统抑制剂的使用与非蛋白尿慢性肾脏病患者的心肾结局:日本肾脏结局改良前沿研究的事后分析

Sugawara, Hirohito; Yoshida, Kiryu; Saito, Chie; Saito, Yoshinori; Kato, Masanori; Kato, Akihiko; Narita, Ichiei; Maruyama, Shoichi; Wada, Jun; Wada, Takashi; Yamamoto, Masahiro; Ito, Hidetoshi; Yamagata, Kunihiro; Ogata, Hiroaki

Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan

日本儿童侵袭性无乳链球菌候选疫苗靶点流行情况及基因组特征

Kasai, Masashi; Nakano, Satoshi; Koide, Shota; Otake, Shogo; Shibata, Meiwa; Ishida-Kuroki, Kasumi; Sugawara, Yo; Akeda, Yukihiro; Nozu, Kandai; Sugai, Motoyuki

Impacts of Mitochondrial Status After Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma Patients

新辅助化疗后线粒体状态对食管鳞状细胞癌患者的影响

Sugawara, Kotaro; Sakashita, Shingo; Fukuda, Takashi; Murakami, Chiaki; Oka, Daiji; Amori, Gulanbar; Baba, Yoshifumi; Kanda, Hiroaki; Motoi, Noriko

IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer

IMpower010:阿特珠单抗治疗日本接受手术切除的IB-IIIA期非小细胞肺癌患者的5年疗效

Okada, Morihito; Sugawara, Shunichi; Watanabe, Yasutaka; Saito, Haruhiro; Chen-Yoshikawa, Toyofumi F; Goto, Yasushi; Nishio, Wataru; Nakagawa, Shizuka; Hayashi, Morihiko; Kenmotsu, Hirotsugu

Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

围手术期纳武利尤单抗治疗可切除非小细胞肺癌:CheckMate 77T研究中日本患者的亚组分析

Tanaka, Fumihiro; Watanabe, Yasutaka; Sugawara, Shunichi; Okami, Jiro; Muto, Satoshi; Okada, Morihito; Horio, Yoshitsugu; Tsuboi, Masahiro; Sato, Yuki; Takamochi, Kazuya; Horinouchi, Hidehito; Tambo, Yuichi; Seike, Masahiro; Okishio, Kyoichi; Coronado Erdmann, Cinthya; Sathyanarayana, Padma; Meadows-Shropshire, Stephanie; Ito, Hiroyuki

Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52

TASUKI-52研究中,纳武利尤单抗联合化疗和贝伐单抗治疗非鳞状非小细胞肺癌患者的四年疗效

Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin-Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Goto, Yasushi; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko